- Home
- PMCB vs SEED Comparison
PMCB vs SEED Comparison
Compare PMCB & SEED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PMCB | SEED |
|---|---|---|
| Founded | 1996 | 1997 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Farming/Seeds/Milling |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.3M | 8.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PMCB | SEED |
|---|---|---|
| Price | $0.67 | $1.04 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 258.8K | 30.0K |
| Earning Date | 03-16-2026 | 01-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $12,823,070.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.63 | $0.74 |
| 52 Week High | $1.90 | $2.49 |
Technical Indicators
Market Signals| Indicator | PMCB | SEED |
|---|---|---|
| Relative Strength Index (RSI) | 37.27 | 32.16 |
| Support Level | $0.65 | $1.01 |
| Resistance Level | $0.81 | $1.26 |
| Average True Range (ATR) | 0.08 | 0.07 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 7.09 | 2.86 |
Price Performance
Historical ComparisonAbout PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About SEED Origin Agritech Limited
Origin Agritech Ltd is a Chinese agricultural technology company operating in the PRC including seed research and development activities featured in crop seed breeding and genetic improvement. The company's phytase corn was the first transgenic corn to receive the Bio-Safety Certificate from China's Ministry of Agriculture. Origin has established a robust biotechnology seed pipeline including products with glyphosate tolerance and pest resistance (Bt) traits.